Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

2B/3, not 3. Phase 3 trials will likely be required.

I’m not sure how you devolved to Anavex talking to me. Of course, as a shareholder Anavex is required to “talk” to ALL shareholders (and the market generally) when there is material news.

Again, 2B/3, not 3.